Estados financieros detallados de PDS Biotechnology Corporation (PDSB): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $0.99, PDSB presenta beneficios negativos (P/E no significativo) y un ROE del -7.08%. La capitalización bursátil es de $55M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $100117 | $182918 | $69118 | $98414 | 0 | 0 | 0 | $57326 | $59791 | 0 |
| Beneficio Bruto | -$100000 | -$183000 | -$69118 | -$98414 | 0 | 0 | 0 | -$57326 | -$59791 | 0 |
| I+D | $24.8M | $34.3M | $830744 | $6.1M | $7.9M | $11.3M | $29.4M | $27.8M | $22.6M | $19.0M |
| Generales y Administrativos | $14.7M | $17.7M | $14.3M | $9.3M | $7.0M | $10.2M | $12.2M | $15.3M | $13.7M | $12.5M |
| Gastos Operativos | $39.5M | $52.0M | $3.6M | $15.4M | $14.9M | $21.4M | $41.7M | $43.0M | $36.3M | $31.5M |
| Beneficio Operativo | -$39.5M | -$52.0M | -$43.1M | -$15.5M | -$14.9M | -$21.4M | -$41.7M | -$43.0M | -$36.3M | -$31.5M |
| EBITDA | -$39.4M | -$51.1M | -$3.6M | -$7.2M | -$14.9M | -$21.4M | -$40.7M | -$40.1M | -$33.7M | -$30.3M |
| Gastos por Intereses | $1.2M | $2.2M | $1.4M | $33559 | 0 | 0 | $1.3M | $4.2M | $4.7M | $5.3M |
| Beneficio Antes de Impuestos | -$40.7M | -$53.4M | -$3.8M | -$7.4M | -$14.8M | -$21.4M | -$42.1M | -$44.3M | -$38.5M | -$35.7M |
| Impuestos | 0 | -$2.6M | -$2.8M | -$381513 | 0 | -$4.5M | -$1.2M | -$1.4M | -$869169 | -$1.2M |
| Beneficio Neto | -$38.8M | -$50.9M | -$40.9M | -$7.0M | -$14.8M | -$16.9M | -$40.9M | -$42.9M | -$37.6M | -$34.5M |
| BPA | $-26.90 | $-33.47 | $-26.16 | $-1.44 | $-0.89 | $-0.66 | $-1.43 | $-1.39 | $-1.03 | $-0.74 |
| BPA Diluido | $-26.90 | $-33.47 | $-10.25 | $-1.44 | $-0.89 | $-0.66 | $-1.43 | $-1.39 | $-1.03 | $-0.74 |
| Acciones en Circulación (Diluidas) | $1.4M | $1.5M | $4.0M | $4.9M | $16.7M | $25.6M | $28.6M | $31.0M | $36.5M | $46.4M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$8.1M | -$6.7M | -$6.5M | -$6.5M |
| EBITDA | -$7.9M | -$6.4M | -$6.3M | -$6.5M |
| Beneficio Neto | -$9.0M | -$7.6M | -$7.3M | -$9.8M |
| BPA | $-0.19 | $-0.14 | $-0.13 | $-0.18 |
| BPA Diluido | $-0.19 | $-0.14 | $-0.13 | $-0.18 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $106.4M | $88.1M | $34.6M | $12.2M | $28.8M | $65.2M | $73.8M | $56.6M | $41.7M | $26.7M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $107.4M | $89.1M | $35.7M | $14.5M | $30.3M | $66.8M | $76.5M | $59.1M | $45.1M | $28.3M |
| Inmovilizado Material | $3.4M | $3.4M | $426952 | $21051 | $553149 | $357697 | $527533 | $335005 | $304214 | $243698 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $51918 | $46805 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $110.9M | $92.6M | $36.2M | $14.5M | $30.9M | $67.2M | $77.0M | $59.4M | $45.4M | $30.5M |
| Cuentas por Pagar | $3.5M | $4.4M | $399447 | $1.2M | $1.4M | $1.3M | $1.2M | $7.0M | $1.7M | $3.6M |
| Deuda a Corto | 0 | $3.1M | 0 | 0 | 0 | 0 | 0 | $4.2M | $12.5M | $5.1M |
| Pasivos Corrientes | $6.7M | $12.9M | $6.4M | $2.8M | $3.3M | $3.8M | $9.8M | $13.6M | $17.1M | $9.5M |
| Deuda a Largo | $15.0M | $17.4M | $30000 | 0 | 0 | 0 | $23.0M | $19.5M | $9.2M | $11.7M |
| Pasivos Totales | $21.6M | $30.2M | $6.4M | $2.8M | $3.8M | $4.0M | $33.0M | $33.3M | $26.4M | $21.2M |
| Reservas | -$101.1M | -$151.9M | -$192.8M | -$28.9M | -$43.8M | -$60.7M | -$101.6M | -$144.5M | -$182.1M | -$216.6M |
| Patrimonio Neto | $89.3M | $62.4M | $29.8M | $11.7M | $27.1M | $63.2M | $44.0M | $26.1M | $19.0M | $9.3M |
| Deuda Total | $15.0M | $20.5M | $30000 | 0 | $610257 | $490354 | $23.5M | $23.9M | $21.8M | $16.9M |
| Deuda Neta | -$91.4M | -$67.6M | -$34.6M | -$12.2M | -$28.2M | -$64.8M | -$50.3M | -$32.7M | -$19.9M | -$9.8M |
| Capital Circulante | $100.7M | $76.2M | $29.3M | $11.7M | $27.1M | $63.1M | $66.7M | $45.4M | $28.0M | $18.8M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $26.2M | $26.7M | $21.7M | $5.6M |
| Activos Totales | $34.7M | $30.5M | $24.7M | $8.8M |
| Pasivos Totales | $25.3M | $21.2M | $20.8M | $12.4M |
| Patrimonio Neto | $9.5M | $9.3M | $3.9M | -$3.6M |
| Deuda Total | $18.0M | $16.9M | $15.9M | $4.4M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$38.8M | -$50.9M | -$40.9M | -$7.0M | -$14.8M | -$16.9M | -$40.9M | -$42.9M | -$37.6M | -$34.5M |
| Amortizaciones | $100117 | $182918 | $69118 | $98414 | $15608 | $5357 | $86 | $17359 | $21112 | $21836 |
| Compensación en Acciones | $5.3M | $6.4M | $7.6M | $3.2M | $452288 | $4.1M | $5.2M | $7.6M | $6.8M | $4.1M |
| Cambio en Capital Circulante | $782432 | $3.1M | -$3.4M | -$4.6M | $1.1M | $75818 | $4.5M | -$199276 | -$5.8M | -$382971 |
| Flujo de Caja Operativo | -$32.2M | -$40.7M | -$33.2M | -$18.1M | -$13.1M | -$12.5M | -$25.7M | -$33.6M | -$35.0M | -$27.8M |
| Inversiones (CapEx) | -$687000 | -$189000 | -$3 | 0 | 0 | 0 | 0 | 0 | -$29000 | 0 |
| Adquisiciones | 0 | 0 | 0 | $29.1M | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$32.9M | -$40.9M | -$33.2M | -$18.1M | -$13.1M | -$12.5M | -$25.7M | -$33.6M | -$35.1M | -$27.8M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$5.9M | -$3.7M | -$4.4M | -$2.8M |
| Inversiones (CapEx) | 0 | $5 | -$4 | 0 |
| Flujo de Caja Libre | -$5.9M | -$3.7M | -$4.4M | -$2.8M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.2M | $1.2M | 0 | 0 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -31.0% | +19.6% | +82.9% | -112.1% | -13.9% | -141.5% | -5.1% | +12.4% | +8.3% |
| Crecimiento BPA (anual) | | -24.4% | +21.8% | +94.5% | +38.2% | +25.8% | -116.7% | +2.8% | +25.9% | +28.2% |
| Cambio en Acciones (anual) | | +5.3% | +162.2% | +22.1% | +244.0% | +52.9% | +11.7% | +8.2% | +17.8% | +27.2% |
| Crecimiento FCF (anual) | | -24.4% | +18.9% | +45.5% | +27.2% | +5.0% | -105.9% | -30.8% | -4.2% | +20.8% |
| Tasa Impositiva Efectiva | -0.0% | 4.8% | 72.5% | 5.2% | -0.0% | 21.1% | 2.9% | 3.2% | 2.3% | 3.3% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-22.78 | $-26.90 | $-8.32 | $-3.71 | $-0.79 | $-0.49 | $-0.90 | $-1.09 | $-0.96 | $-0.60 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.4M | $1.5M | $166867 | $4.9M | $16.7M | $25.6M | $28.6M | $31.0M | $36.5M | $46.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -708.20% |
| Rentabilidad sobre capital invertido | -3550.39% |
| Rentabilidad sobre activos | -382.32% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | -1.22 |
| Ratio corriente | 0.57 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -11.61 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -9.29 | -5.60 | -0.25 | -1.84 | -2.40 | -12.27 | -9.23 | -3.58 | -1.58 | -1.04 |
| P/VC | 4.04 | 4.57 | 0.04 | 1.10 | 1.32 | 3.28 | 8.58 | 5.89 | 3.13 | 3.86 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |